Caricamento...
Biosimilars: the process is the product. The example of recombinant streptokinase
BACKGROUND: Worldwide, streptokinase remains the most used thrombolytic agent for the treatment of myocardial infarction. Recombinant streptokinase, from E. coli, is increasingly used in developing countries as a biosimilar of native streptokinase; however, potency assignments relative to the WHO In...
Salvato in:
| Pubblicato in: | J Thromb Haemost |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
BlackWell Publishing Ltd
2014
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4241032/ https://ncbi.nlm.nih.gov/pubmed/24913658 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jth.12629 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|